Capecitabine in breast cancer: The issue of cardiotoxicity during fluoropyrimidine treatment

Breast Journal

Volumn 16, Issue SUPPL. 1, 2010, Pages

  Molteni, Luisa P ^a   Rampinelli, Irene ^a   Cergnul, Massimiliano ^a   Scaglietti, Ugo ^a   Paino, Anna M ^b   Noonan, Douglas M ^c   Bucci, Eraldo O ^a   Gottardi, Ornella ^a   Albini, Adriana ^a  

^a IRCCS MULTIMEDICA   (Italy)

^b Borgomanero Hospital   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

breast cancer; capecitabine; cardiogenic shock; cardiotoxicity; fluoropyrimidine

Indexed keywords

ANASTROZOLE; BISOPROLOL; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOPAMINE; DOXORUBICIN; ENOXAPARIN; EXEMESTANE; FLUOROURACIL; FULVESTRANT; GEMCITABINE; LETROZOLE; LUTEINIZING HORMONE DERIVATIVE; METHYLPREDNISOLONE; NAVELBINE; PACLITAXEL; PEMETREXED; TAMOXIFEN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ADVANCED CANCER; ANGINA PECTORIS; ASTHENIA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY SPASM; DIARRHEA; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HAND FOOT SYNDROME; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; HYPOTENSION; LUNG EDEMA; MASTECTOMY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; REVIEW; SIDE EFFECT; SINUS TACHYCARDIA; SUDDEN DEATH; T WAVE INVERSION; TACHYCARDIA; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DEOXYCYTIDINE; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY; FEMALE; FLUOROURACIL; HEART ATRIA; HEART FAILURE; HUMANS; SHOCK, CARDIOGENIC; TACHYCARDIA, SINUS; TROPONIN I; VENA CAVA, SUPERIOR;

EID: 78649236180     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01004.x     Document Type: Review

References (23)

1. Online. http://www.cancer.gov/cancertopics/druginfo/capecitabine.
2. Bertolini A, Flumano M, Fusco O, et al. Acute cardiotoxicity during capecitabine treatment: a case report. Tumori 2001; 87: 200 -6.
3. Yeh ET, Bickford CL,. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 2009; 53: 2231 -47.
4. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM,. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 2010; 102: 14 -25.
5. Saif MW, Shah MM, Shah AR,. Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf. 2009; 8: 191 -202.
6. Van Cutsem E, Hoff PM, Blum JL, Abt M, Osterwalder B,. Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Ann Oncol 2002; 13: 484 -5.
7. Maurer U, Harle M, Jungius KP,. 5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy? Strahlenther Onkol 1996; 172: 257 -9.
8. Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M,. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol 2002; 13: 797 -801.
9. Goldsmith YB, Roistacher N, Baum MS,. Capecitabine-induced coronary vasospasm. J Clin Oncol 2008; 26: 3802 -4.
10. Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G,. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori. 1982; 68: 505 -10.
11. Kosmas C, Kallistratos MS, Kopterides P, et al. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 2008; 134: 75 -82.
12. Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J,. 5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987; 294: 238 -43.
13. Eskilsson J, Albertsson M,. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil. Acta Oncol 1990; 29: 1001 -3.
14. Labianca R, Luporini G,. 5-fluorouracil cardiotoxicity: the risk of rechallenge. Ann Oncol 1991; 2: 383.
15. Oleksowicz L, Bruckner HW,. Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers. Am J Med 1988; 85: 750 -1.
16. Dalzell JR, Samuel LM,. The spectrum of 5-fluorouracil cardiotoxicity. Anticancer Drugs 2009; 20: 79 -80.
17. Ang C, Kornbluth M, Thirlwell MP, Rajan RD,. Capecitabine-induced cardiotoxicity: case report and review of the literature. Curr Oncol. 2010; 17: 59 -63.
18. Cwikiel M, Eskilsson J, Albertsson M, Stavenow L,. The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture. Ann Oncol 1996; 7: 731 -7.
19. Cwikiel M, Zhang B, Eskilsson J, Wieslander JB, Albertsson M,. The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits. Scanning Microsc 1995; 9: 561 -76.
20. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME,. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994; 10: 861 -4.
21. Durak I, Karaayvaz M, Kavutcu M, et al. Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil. J Toxicol Environ Health A. 2000; 59: 585 -9.
22. Timour Q, Aupetit JF, Freysz M, Frassati D, Faucon G,. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes. Can J Physiol Pharmacol 1996; 74: 1308 -14.
23. Zambelli A, Porta MD, Rosti V,. From cancer patients to cancer survivors: the issue of Cardioncology-a biological perspective. Eur J Cancer 2010; 46: 697 -702.